Utilisation, effectiveness, and safety of immediate postpartum intrauterine device insertion: a systematic literature review
- PMID: 36600467
- PMCID: PMC10176355
- DOI: 10.1136/bmjsrh-2022-201579
Utilisation, effectiveness, and safety of immediate postpartum intrauterine device insertion: a systematic literature review
Abstract
Background: Intrauterine devices (IUDs) are highly effective contraception. IUDs inserted directly following delivery provide immediate birth control and may decrease unintended pregnancies, including short-interval pregnancies, thereby mitigating health risks and associated economic burden.
Methods: This systematic literature review included published global data on the utilisation, effectiveness, and safety of postpartum intrauterine devices (PPIUDs) of any type. English language articles indexed in MEDLINE, Embase, and Cochrane from January 2010-October 2021 were included.
Results: 133 articles met the inclusion criteria (46% interventional studies; 54% observational; n=87 from lower-income countries; n=46 from higher-income countries). PPIUD use was low in higher-income countries (6/10 000 US deliveries in 2013-2016) and varied widely in lower-income countries (2%-46%). Across both higher- and lower-income countries, in most studies (79%), >80% of women with PPIUDs had an IUD in place by 3 months; at 6 and 12 months, 76% and 54% of included studies reported that >80% of women had an IUD in place; reason for discontinuation was infrequently reported. Pregnancies were rare (96 pregnancies across 12 191 women from 37 studies reporting data) and were generally unrelated to device failure, but rather occurred in women no longer using a PPIUD. Expulsions occurred mainly in the early outpatient period and ranged widely (within 3 months: 0-41%). Abnormal bleeding, infections, or perforations were rare.
Conclusions: PPIUDs are safe and effective. Long-term follow-up data are limited. Future research elucidating reasons underlying lack of PPIUD use is warranted.
Keywords: contraceptive effectiveness; intrauterine devices; long-acting reversible contraception; patient safety.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: EG-E reports personal fees from Xcenda LLC, during the conduct of the study. JL reports personal fees, non-financial support and other from Bayer US LLC, outside the submitted work. KRB, YW, NW, and FP are all employees of Bayer, which manufactures IUDs among its portfolio of products.
Figures


Similar articles
-
Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.Cochrane Database Syst Rev. 2022 Oct 27;10(10):CD011913. doi: 10.1002/14651858.CD011913.pub3. Cochrane Database Syst Rev. 2022. PMID: 36302159 Free PMC article.
-
Immediate postabortal insertion of intrauterine devices.Cochrane Database Syst Rev. 2002;(3):CD001777. doi: 10.1002/14651858.CD001777. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001777. doi: 10.1002/14651858.CD001777.pub2. PMID: 12137634 Updated.
-
Postpartum intrauterine contraceptive device use and its associated factors in Ethiopia: systematic review and meta-analysis.Reprod Health. 2021 Nov 13;18(1):225. doi: 10.1186/s12978-021-01273-x. Reprod Health. 2021. PMID: 34774058 Free PMC article.
-
Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.Cochrane Database Syst Rev. 2004;2004(3):CD001776. doi: 10.1002/14651858.CD001776.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266453 Free PMC article.
-
Education for contraceptive use by women after childbirth.Cochrane Database Syst Rev. 2002;(3):CD001863. doi: 10.1002/14651858.CD001863. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD001863. doi: 10.1002/14651858.CD001863.pub2. PMID: 12137636 Updated.
Cited by
-
Expanding access to postpartum contraception.Curr Opin Obstet Gynecol. 2024 Oct 1;36(5):331-337. doi: 10.1097/GCO.0000000000000982. Epub 2024 Aug 2. Curr Opin Obstet Gynecol. 2024. PMID: 39109628 Free PMC article. Review.
-
Clinician and policymaker perspectives on the barriers and enablers to implementing and scaling up integrated postpartum intrauterine contraceptive services within maternity care in Nepal: a qualitative study.Lancet Reg Health Southeast Asia. 2025 May 14;37:100599. doi: 10.1016/j.lansea.2025.100599. eCollection 2025 Jun. Lancet Reg Health Southeast Asia. 2025. PMID: 40487913 Free PMC article.
-
Follow-up of immediate postpartum intrauterine device insertion: a scoping review protocol.BMJ Open. 2024 Dec 20;14(12):e092783. doi: 10.1136/bmjopen-2024-092783. BMJ Open. 2024. PMID: 39806629 Free PMC article.
References
-
- Unintended pregnancy. Available: https://www.cdc.gov/reproductivehealth/contraception/unintendedpregnancy... [Accessed 23 Mar 2021].
-
- Our world in data, number of births per year, world. Available: https://ourworldindata.org/grapher/births-and-deaths-projected-to-2100?c... [Accessed 23 Mar 2021].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous